# Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean

> **NCT03364491** · PHASE3 · COMPLETED · sponsor: **The George Washington University Biostatistics Center** · enrollment: 11000 (actual)

## Conditions studied

- Obstetrical Complications
- Hemorrhage
- Labor and Delivery

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03364491
- **Lead sponsor:** The George Washington University Biostatistics Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2021-07-24
- **Final completion:** 2021-10-29
- **Target enrollment:** 11000 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03364491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03364491, "Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03364491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*